Anti-Aging Drugs Market

Analysis by Type (Dermal Fillers, Botulinum Toxin, and Others); by Drug Class (Hormonal Therapy, Antioxidants, Enzymes, and Stem Cells); by Application (Skincare, Haircare, and Age-Related Disorders); and by Distribution Channel (Retail Pharmacies, and Online Pharmacies) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033

Buy Now
Report ID: 375 | Published On: Feb 13, 2023
Request Free Sample Copy

Global Anti-Aging Drugs Market Size, Forecast, and Trend Highlights Over 2023 - 2033

The global anti-aging drugs market is estimated to garner a revenue of ~USD 95 billion by the end of 2033 by growing at a CAGR of ~7% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of ~USD 49 billion in the year 2022. The growth of the market can be attributed primarily to the rising aging population around the world with the rising hope for extending the healthy lifespan of humans having youthful characteristics. According to the World Health Organization, globally, the percentage of people over 60 years of age will nearly double from 12% to 22% between 2015 and 2050.

Anti-Aging-Drugs-Market overviewGet more information on this report:Request Sample PDF

In the prevention and treatment of age-related disorders and diseases, anti-aging drugs combine advanced biotechnology and clinical prevention medicines. Anti-aging drugs are mostly used by the baby boomer generation, as well as by consumers who care more about their health and appearance. Using these drugs, the body is able to reverse the effects of aging. The aging process is also being delayed through a wide variety of medical technologies.

Anti-Aging-Drugs-Market overview
Get more information on this report: Request Sample PDF

Global Anti-Aging Drugs Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2022)

~ USD 49 Billion

Forecast Year Market Size (2033)

~ USD 95 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)

Global Anti-Aging Drugs Market: Growth Drivers and Challenges

Growth Drivers

  • Growing Prevalence of Photoaging Among People - premature aging of the skin is caused by sun exposure. Skin damage caused by the sun is referred to by a number of names in dermatology, including photoaging. Certainly, UV exposure causes more visible signs of facial aging. Thus, the rising cases of photoaging are expected to propel the demand for anti-aging drugs during the forecast period. It was observed that, approximately 90% of European and North American adults with skin phototypes I, II, and III show clinically detectable photoaging.

  • An Increasing Number of Dermatologists - for instance, nearly 3,700 dermatologists are presently employed in the United States. Women account for over 85% of dermatologists, while men account for 14%.

  • Rising Personal Disposable Income - according to the Bureau of Economic Analysis, in July 2022 disposable personal income (DPI) increased by USD 37.6 billion (0.2%) in United States.

  • Increasing Level of Chronic Stress Among People- it was observed that globally, approximately 33% of people admitted feeling stressed.

  • Excessive Alcohol Consumptionaccording to the Centers for Diseases Control and Prevention, nearly 16% of adults are excessive alcohol drinkers, and 6% are reported, as heavy drinkers.


  • High Cost of Anti-Aging Drugs - medical research and funding is vital and central for the development of aging-related medications. With huge funds invested in the scientific research and development of these drugs, it is still unaffordable for many.

  • Low Awareness of Anti-Aging Drugs in Low-Income Countries

  • Presence of Alternatives in the Market

The global anti-aging drugs market is segmented and analyzed for demand and supply by type into dermal fillers, botulinum toxin, and others. Among these segments, the dermal fillers segment is anticipated to capture the largest market size in the global anti-aging drugs market owing to the increasing dermal filler injections and higher adoption of derma fillers in treating wrinkles and fine lines. For instance, it was found that in 2018, there were approximately 2.6 million dermal filler injections in America.

Global Anti-Aging Drugs Market Regional Synopsis

The North America anti-aging drugs market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033, backed by the increasing number of non-invasive cosmetic treatments, the growing demand for anti-aging products, and the rapid expansion of the personal care industry. For instance, in 2020 nearly 13,280,000 cosmetic minimally invasive surgery procedures were carried out in the United States.


Market Segmentation

Our in-depth analysis of the global anti aging drugs market includes the following segments:

        By Type

  • Dermal Fillers
  • Botulinum Toxin
  • Others

      By Drug Class

  • Hormonal Therapy
  • Antioxidants
  • Enzymes
  • Stem Cells

      By Application

  • Skincare
  • Haircare
  • Age-Related Disorders

     By Distribution Channel

  • Retail Pharmacies
  • Online Pharmacies

Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the Global Anti-Aging Drugs Market

    • L’Oreal  SA

      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Merz Pharma GmbH & Co.
    • Novartis AG
    • BioTime Inc.
    • ARK Skincare
    • Elysium Health Inc.
    • Estee Lauder Inc.
    • DermaFix
    • Bayer Pharma AG
    • La Roche-Posay

In The News

  • April 2022: IBSRELA the first and only NHE3 inhibitor for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults, has been made available by the biopharmaceutical company Ardelyx. The first Ardelyx product to receive approval from the US Food and Drug Administration is IBSRELA.
  • March 2022: Indegene a provider of technology-driven healthcare solutions, & meta Me Health, a maker of Regulora and a Prescription Digital Therapeutics (PDT) business, teamed up to offer Regulora as a remedy for irritable bowel syndrome-related stomach pain (IBS).

Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Key Questions Answered in the Report

1) What are the major factors driving the growth of the anti-aging drugs market?

Ans: Rising adoption of anti aging products, desire to look young and healthy among elderly people along with increasing disposable income are the major factors driving the growth of the anti aging drugs market.

2) What would be the CAGR of anti-aging drugs market over the forecast period?

Ans: The market is anticipated to attain a CAGR of ~10% over the forecast period, i.e., 2023 – 2033.

3) What are the challenges affecting the anti-aging drugs market growth?

Ans: High cost associated with anti aging products is expected to hinder market growth.

4) Which region will provide more business opportunities for growth of anti-aging drugs market in future?

Ans: The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

5) Who are the major players dominating the anti-aging drugs market?

Ans: The major players in the market are Nu Skin Enterprises, Novartis AG, BioTime Inc., ARK Skincare, Elysium Health Inc., Estee Lauder Inc., DermaFix, Bayer Pharma AG, La Roche-Posay, L’Oreal SA, Merz Pharma GmbH & Co.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the anti aging drugs market?

Ans: The market is segmented by type, drug class, application, distribution channel, and, by region.

8) Which segment captures the largest market size in type segment in the anti aging drugs market?

Ans: The dermal filler segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Request Research Report Sample